Reflections on renal denervation

Journal of the American College of Cardiology

Volumn 63, Issue 14, 2014, Pages 1452-1453

  Demaria, Anthony N ^a  

^a AMERICAN COLLEGE OF CARDIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); EDITORIAL; HUMAN; KIDNEY DENERVATION; META ANALYSIS (TOPIC); PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RADIOFREQUENCY ABLATION; RESEARCH PRIORITY; RESISTANT HYPERTENSION; RISK BENEFIT ANALYSIS; THERAPY EFFECT; TREATMENT INDICATION; CLINICAL TRIAL (TOPIC); PUBLICATION; TREATMENT FAILURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CONTROLLED CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SYMPATHECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84898016623     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.001     Document Type: Editorial

References (14)

1. D.E. Kandzari, and P.A. Sobotka Ready for a marathon, not a sprint: renal denervation therapy for treatment-resistant hypertension J Am Coll Cardiol 62 2013 2131 2133
2. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, M. Böhm for the Symplicity HTN-2 Investigators Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 2010 1903 1909
3. D.E. Kandzari, D.L. Bhatt, and P.A. Sobotka et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial Clin Cardiol 35 2012 528 535
4. Medtronic. Medtronic announces U.S. renal denervation pivotal trial fails to meet primary efficacy endpoint while meeting primary safety endpoint. Available at: http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol- newsArticle&ID=1889335&highlight=. Accessed March 10, 2014.
5. B.P. Geisler, B.M. Egan, and J.T. Cohen et al. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension J Am Coll Cardiol 60 2012 1271 1277
6. M.C. Brandt, F. Mahfoud, and S. Reda et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension J Am Coll Cardiol 59 2012 901 909
7. M.I. Davis, K.B. Filion, and D. Zhang et al. Effectiveness of renal denervation therapy for resistant hypertension J Am Coll Cardiol 62 2013 231 241
8. C. Ott, F. Mahfoud, and A. Schmid et al. Renal denervation in moderate treatment-resistant hypertension J Am Coll Cardiol 62 2013 1880 1886
9. E. Pokushalov, A. Romanov, and G. Corbucci et al. A randomized comparison of pulmonary vein isolation with versus with without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension J Am Coll Cardiol 60 2012 1163 1170
10. Y. Jin, A. Persu, and J.A. Staessen Renal denervation in the management of resistant hypertension Curr Opin Nephrol Hypertens 22 2013 511 518
11. M.C. Brandt, S. Reda, F. Mahfoud, M. Lenski, M. Bohm, and U.C. Hoppe Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension J Am Coll Cardiol 60 2012 1956 1965
12. O'Riordan M. SYMPLICITY THN-3 Complicates Renal-Denervation Field, Say Experts. Heartwire, January 10, 2014.
13. M.P. Schlaich, R.E. Schmieder, and G. Bakris et al. International Expert Consensus Statement J Am Coll Cardiol 62 2013 2031 2045
14. C.Z. Zuern, C. Eick, and K.D. Rizas et al. Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension J Am Coll Cardiol 62 2013 2124 2130